October 13, 2026
Oncology remains one of the largest areas of clinical research investment, accounting for the highest volume of completed studies when compared to other therapeutic areas. Data from Citeline’s 2026 Annual Completed Clinical Trials report showcases nearly 2x as many oncology trials completed in 2025 (1,421 trials) than trials completed within the second leading TA by volume, autoimmune/inflammation (719 trials).
This popularity creates an interesting challenge during CRO selection –
Since oncology accounts for such a significant portion of clinical trials conducted, nearly every CRO can point to oncology experience. However – as sponsors who have been burned by a CRO before can attest – organizational experience alone does not guarantee that the team managing your study possesses the specialized expertise a complex oncology trial requires.
Our Oncology CRO Selection Workbook was designed with this complexity in mind.
What’s in our Oncology CRO Selection Workbook?
The Oncology CRO Selection Workbook was designed as an interactive resource to help your team approach the CRO selection process with greater clarity and consistency
The workbook includes guided areas for defining what you need from a CRO, identifying the challenges and priorities that may shape your study, and providing questions that can be used to evaluate potential partners based on capabilities, experience, and approach.
Contents:
- An Introduction: What Makes Oncology Clinical Trials So Uniquely Complex
- Part One: Clarifying Your Outsourcing Needs
- Part Two: Questions to Ask Prospective CROs
For Instant Access, Complete the Form Below